A Randomized Controlled Multicenter Study of Artificial Intelligence Assisted Digestive Endoscopy

NCT ID: NCT04071678

Last Updated: 2019-10-22

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

3600 participants

Study Classification

OBSERVATIONAL

Study Start Date

2019-08-01

Study Completion Date

2021-12-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Digestive endoscopy center of the second affiliated hospital of medical college of zhejiang university and engineers of naki medical co., ltd. in Hong Kong independently developed an ai-assisted diagnostic model of digestive endoscopy in the early stage, namely the deep learning model.The deep learning model through the early stage of the study, is able to identify lesions of digest tract.The sensitivity for the diagnosis of some diseases, such as colon polyps, is 99%. On the one hand, this auxiliary diagnostic model can guide endoscopic examination for beginners; on the other hand, it can improve the detection rate of lesions and reduce the rate of missed diagnosis; on the other hand, the overall operating efficiency of the endoscopic center is improved, which is conducive to the quality control of endoscopic examination. Now the AI-assisted diagnostic model has been further improved, and it is planned to carry out further clinical verification in the digestive endoscopy center of our hospital. It is connected to the endoscopic system of our hospital and used simultaneously with the existing image-text system of endoscopy to compare the practicability, sensitivity and specificity of AI-assisted diagnosis model in the diagnosis of digestive tract diseases, and focus on the quality control of endoscopic examination.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Digestive endoscopy center of the second affiliated hospital of medical college of zhejiang university and engineers of naki medical co., ltd. in Hong Kong independently developed an ai-assisted diagnostic model of digestive endoscopy in the early stage, namely the deep learning model。The deep learning model through the early stage of the study, is able to identify lesions of colon polyps, colorectal cancer, colorectal apophysis lesions, colonic diverticulum, ulcerative colitis, gastric ulcer, gastric polyps, submucosal uplift, reflux esophagitis, esophageal ulcer, esophageal polyp, esophageal erosion, esophageal ectopic gastric mucosa and esophagus varicosity, esophageal cancer, esophageal papilloma, etc.The sensitivity for the diagnosis of some diseases, such as colon polyps, is 99%. On the one hand, this auxiliary diagnostic model can guide endoscopic examination for beginners; on the other hand, it can improve the detection rate of lesions and reduce the rate of missed diagnosis; on the other hand, the overall operating efficiency of the endoscopic center is improved, which is conducive to the quality control of endoscopic examination. Now the AI-assisted diagnostic model has been further improved, and it is planned to carry out further clinical verification in the digestive endoscopy center of our hospital. It is connected to the endoscopic system of our hospital and used simultaneously with the existing image-text system of endoscopy to compare the practicability, sensitivity and specificity of AI-assisted diagnosis model in the diagnosis of digestive tract diseases, and focus on the quality control of endoscopic examination.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Artificial Intelligence

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

A: Model A

Mode A was silent mode, back-to-back with endoscopic physicians to simultaneously display endoscopic images and record video, but did not interfere with the operation of endoscopic physicians.After the operation, the AI model automatically generates an endoscopy report, which is compared with the official report given by the endoscopy doctor in the endoscopy system. If the difference is large, video verification shall be played back immediately or endoscopic examination shall be performed again before the patient wakes up

Careful examination during endoscopic procedures to identify lesions

Intervention Type BEHAVIORAL

When the AI model alarms, check carefully to confirm the lesion

B: Model B

Mode B is a delayed reminder mode. If the lesion is found during the operation, it is required to be moved to the middle of the visual field within 5 seconds. If the lesion has been detected by the AI model (the lesion has been circled in the picture), but the doctor does not move the lesion to the middle of the visual field within 5 seconds, the AI system will give an alarm prompt

Careful examination during endoscopic procedures to identify lesions

Intervention Type BEHAVIORAL

When the AI model alarms, check carefully to confirm the lesion

C: Model C

Mode C is a real-time reminder mode, which is an alarm prompt when the focus is captured in the visual field.

Careful examination during endoscopic procedures to identify lesions

Intervention Type BEHAVIORAL

When the AI model alarms, check carefully to confirm the lesion

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Careful examination during endoscopic procedures to identify lesions

When the AI model alarms, check carefully to confirm the lesion

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Voluntarily sign the informed consent for this study
* Stable vital signs
* Over 18 years old
* Patients requiring painless gastroenteroscopy for various reasons

Exclusion Criteria

* Unable or unwilling to sign a consent form, or unable to follow research procedures
* have contraindications to painless gastroenteroscopy
* Vital signs are unstable
* The lesions have been identified by gastroenteroscopy in other hospitals, which is to further confirm the patients who come to our hospital for endoscopic examination
* Endoscopic treatment, such as polypectomy, pylorus narrow dilatation and so on
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Second Affiliated Hospital, School of Medicine, Zhejiang University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Cai J Ting, Dr

Role: STUDY_DIRECTOR

Second affiliated hospital of school of medicine, zhejiang university

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Cai J Ting

Hangzhou, Zhejiang, China

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

China

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Wang J An, Dr

Role: CONTACT

057187783759 ext. 057187783759

Cai J Ting, Dr

Role: CONTACT

15267019902 ext. 15267019902

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Cai J Ting

Role: primary

15267019902 ext. 15267019902

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

研2019-262

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.